Quest rises as it starts selling COVID-19 tests without doctor visits Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Quotient (QTNT) up 29% after announcing what it called "very strong final study performance data" for its SARS-CoV-2 antibody test
- Quest Diagnostics (DGX) up 7.5% after announcing that individuals can purchase COVID-19 antibody testing for themselves online, without visiting a doctor's office, through QuestDirect, the company's consumer-initiated testing business
- SmileDirectClub (SDC) up 33% after annoucing its award for a patent for its SmileShop intellectual property and saying it is making plans to "slowly reopen" its SmileShops beginning in May
UP AFTER EARNINGS -
- F5 Networks (FFIV) up 12%
- Harley-Davidson (HOG) up 6%
- PepsiCo (PEP) up 2%
- 3M (MMM) up 4%
- Caterpillar (CAT) up 1%
DOWN AFTER EARNINGS -
- UPS (UPS) down 4%
- Merck (MRK) down 2.5%
ALSO LOWER -
- Blueprint Medicines (BPMC) down 13% after reporting that the Phase 3 VOYAGER clinical trial of avapritinib versus regorafenib in patients with locally advanced unresectable or metastatic gastrointestinal stromal tumor, or GIST, did not meet the primary endpoint of an improvement in progression-free survival, or PFS
Symbols:
UPS MRK DGX QTNT FFIV HOG BPMC SDC PEP MMM - $153.67 /
+6.675 (+4.54%)
CAT Keywords: Wall Street; top news